Related Experiment Video
Updated: Jun 20, 2026

Deciphering the Structural Effects of Activating EGFR Somatic Mutations with Molecular Dynamics Simulation
Published on: May 20, 2020
The dopamine D4 receptor activates intracellular platelet-derived growth factor receptor beta to stimulate ERK1/2
Robin S Gill1, Marilyn S Hsiung, Chi S Sum
1Centre for Addiction and Mental Health, Toronto, Ontario, Canada.
Abstract:
Dopamine receptors are GPCRs that play important roles in locomotion, reward, and cognitive processes. Previously, we demonstrated that this receptor transactivates PDGFRbeta to modulate ERK1/2 and NMDA receptor activity. Downregulation of maturely glycosylated PDGFRbeta by prolonged exposure to PDGF-BB eliminated PDGF-BB-mediated ERK1/2 activation. The DRD4-mediated ERK1/2 response was only partially blunted by PDGF-BB-mediated downregulation, but remained sensitive to the PDGFRbeta kinase inhibitor tyrphostin A9. Tunicamycin prevented the N-linked glycosylation and maturation of PDGFRbeta as well as its activation by PDGF-BB. However, upon tunicamycin treatment, DRD4 continued to signal to ERK1/2 in a tyrphostin A9-sensitive manner. Collectively, our observations indicate that DRD4, unlike PDGF-BB, can activate a pool of intracellularly located PDGFRbeta.
Insights
Dopamine receptors (DRD4) activate intracellular PDGF-beta receptors independently of external growth factors. This signaling pathway bypasses normal receptor maturation, offering new insights into dopamine receptor function.
Area of Science:
- Neuroscience
- Cellular Signaling
- GPCR Research
Background:
- Dopamine receptors (GPCRs) are crucial for locomotion, reward, and cognition.
- Previous work showed dopamine receptor transactivation of PDGF-beta receptor (PDGFRbeta) influences ERK1/2 and NMDA receptor activity.
Purpose of the Study:
- To investigate the mechanism by which dopamine receptor D4 (DRD4) signals to PDGFRbeta.
- To determine if DRD4 activation of PDGFRbeta is dependent on external growth factors and receptor glycosylation.
Main Methods:
- Cells were treated with PDGF-BB to induce PDGFRbeta downregulation.
- Tunicamycin was used to inhibit N-linked glycosylation and maturation of PDGFRbeta.
- ERK1/2 activation was measured in response to DRD4 signaling and PDGFRbeta kinase inhibition (tyrphostin A9).
Main Results:
- PDGF-BB-mediated ERK1/2 activation was abolished by PDGFRbeta downregulation.
- DRD4-mediated ERK1/2 activation was only partially reduced by PDGFRbeta downregulation and remained sensitive to tyrphostin A9.
- Tunicamycin treatment blocked PDGFRbeta activation by PDGF-BB, but DRD4 signaling to ERK1/2 persisted in a tyrphostin A9-sensitive manner.
Conclusions:
- Dopamine receptor D4 can activate intracellular PDGFRbeta, independent of external PDGF-BB.
- This DRD4-mediated signaling bypasses the need for PDGFRbeta maturation and glycosylation.
- DRD4 utilizes a distinct mechanism to activate PDGFRbeta compared to its cognate ligand, PDGF-BB.
Related Concept Videos
MAPK Signaling Cascades
Enzyme-linked Receptors
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
Enzyme-linked Receptors
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
Receptor Tyrosine Kinases
IP3/DAG Signaling Pathway
Amplifying Signals via Second Messengers

